186 related articles for article (PubMed ID: 19404736)
41. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
42. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
Puget N; Torchard D; Serova-Sinilnikova OM; Lynch HT; Feunteun J; Lenoir GM; Mazoyer S
Cancer Res; 1997 Mar; 57(5):828-31. PubMed ID: 9041180
[TBL] [Abstract][Full Text] [Related]
43. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3' splice site.
Doktor TK; Schroeder LD; Vested A; Palmfeldt J; Andersen HS; Gregersen N; Andresen BS
Hum Mutat; 2011 Feb; 32(2):220-30. PubMed ID: 21120954
[TBL] [Abstract][Full Text] [Related]
44. BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels.
Zhang L; Chen L; Bacares R; Ruggeri JM; Somar J; Kemel Y; Stadler ZK; Offit K
Breast Cancer Res Treat; 2011 Dec; 130(3):1051-6. PubMed ID: 21863257
[TBL] [Abstract][Full Text] [Related]
45. Identification of a new complex rearrangement affecting exon 20 of BRCA1.
Del Valle J; Campos O; Velasco A; Darder E; Menéndez M; Feliubadaló L; Tornero E; Blanco I; Izquierdo A; Brunet J; Capellá G; Lázaro C
Breast Cancer Res Treat; 2011 Nov; 130(1):341-4. PubMed ID: 21761158
[TBL] [Abstract][Full Text] [Related]
46. Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.
Ruiz de Garibay G; Fernandez-Garcia I; Mazoyer S; Leme de Calais F; Ameri P; Vijayakumar S; Martinez-Ruiz H; Damiola F; Barjhoux L; Thomassen M; Andersen LVB; Herranz C; Mateo F; Palomero L; Espín R; Gómez A; García N; Jimenez D; Bonifaci N; Extremera AI; Castaño J; Raya A; Eyras E; Puente XS; Brunet J; Lázaro C; ; ; Radice P; Barnes DR; Antoniou AC; Spurdle AB; de la Hoya M; Baralle D; Barcellos-Hoff MH; Pujana MA
Hum Mutat; 2021 Nov; 42(11):1488-1502. PubMed ID: 34420246
[TBL] [Abstract][Full Text] [Related]
47. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB
Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870
[TBL] [Abstract][Full Text] [Related]
48. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
[TBL] [Abstract][Full Text] [Related]
49. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
50. Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat.
Cortesi L; De Nicolo A; Medici V; Marino M; Turchetti D; Pradella LM; Rossi G; Parisini E; Federico M
Breast Cancer Res Treat; 2012 Jul; 134(1):435-41. PubMed ID: 22527099
[TBL] [Abstract][Full Text] [Related]
51. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
[TBL] [Abstract][Full Text] [Related]
52. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
Goina E; Skoko N; Pagani F
Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
Yang C; Jairam S; Amoroso KA; Robson ME; Walsh MF; Zhang L
Breast Cancer Res Treat; 2018 Apr; 168(2):543-550. PubMed ID: 29185120
[TBL] [Abstract][Full Text] [Related]
54. Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant.
Minucci A; Lalle M; De Leo R; Mazzuccato G; Scambia G; Urbani A; Fagotti A; Concolino P; Capoluongo E
Clin Biochem; 2019 Jan; 63():54-58. PubMed ID: 30315757
[TBL] [Abstract][Full Text] [Related]
55. Alternative splicing and molecular characterization of splice site variants: BRCA1 c.591C>T as a case study.
Dosil V; Tosar A; Cañadas C; Pérez-Segura P; Díaz-Rubio E; Caldés T; de la Hoya M
Clin Chem; 2010 Jan; 56(1):53-61. PubMed ID: 19892845
[TBL] [Abstract][Full Text] [Related]
56. Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes.
Menéndez M; Castellsagué J; Mirete M; Pros E; Feliubadaló L; Osorio A; Calaf M; Tornero E; del Valle J; Fernández-Rodríguez J; Quiles F; Salinas M; Velasco A; Teulé A; Brunet J; Blanco I; Capellá G; Lázaro C
Breast Cancer Res Treat; 2012 Apr; 132(3):979-92. PubMed ID: 21735045
[TBL] [Abstract][Full Text] [Related]
57. BRCA2 T2722R is a deleterious allele that causes exon skipping.
Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
[TBL] [Abstract][Full Text] [Related]
58. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes.
Théry JC; Krieger S; Gaildrat P; Révillion F; Buisine MP; Killian A; Duponchel C; Rousselin A; Vaur D; Peyrat JP; Berthet P; Frébourg T; Martins A; Hardouin A; Tosi M
Eur J Hum Genet; 2011 Oct; 19(10):1052-8. PubMed ID: 21673748
[TBL] [Abstract][Full Text] [Related]
59. Cooperative-binding and splicing-repressive properties of hnRNP A1.
Okunola HL; Krainer AR
Mol Cell Biol; 2009 Oct; 29(20):5620-31. PubMed ID: 19667073
[TBL] [Abstract][Full Text] [Related]
60. Differential hnRNP D isoform incorporation may confer plasticity to the ESSV-mediated repressive state across HIV-1 exon 3.
Hillebrand F; Peter JO; Brillen AL; Otte M; Schaal H; Erkelenz S
Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):205-217. PubMed ID: 27919832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]